Hospital and Physician Update

January – February 2021

MAT waiver training opportunities available in 2021

According to the American Medical Association, more than 40 states have reported increases in opioid-related mortality since the start of the COVID-19 pandemic. Blue Cross Blue Shield of Michigan and its partners remain committed to expanding access to medication-assisted treatment for opioid use disorder during these challenging times.

Health care providers must complete an eight-hour training course to qualify for a Drug Enforcement Administration waiver to prescribe and dispense buprenorphine as required by the Drug Addiction Treatment Act of 2000. Training opportunities, certified by the American Society of Addiction Medicine, are available that satisfy the DEA waiver requirements. Training covers treating opioid use disorder using interactive, case-based learning and evidence-based practices.

Zoom-based MAT waiver training courses will be offered to health care providers from January through March 2021, with in-person training anticipated to resume later in the year.

Here’s additional information on upcoming courses:

*Blue Cross Blue Shield of Michigan doesn’t own or control this website.

No portion of this publication may be copied without the express written permission of Blue Cross Blue Shield of Michigan, except that BCBSM participating health care providers may make copies for their personal use. In no event may any portion of this publication be copied or reprinted and used for commercial purposes by any party other than BCBSM.

Blue Cross Blue Shield of Michigan and Blue Care Network are nonprofit corporations and independent licensees of the Blue Cross and Blue Shield Association.